Related Experiment Video
Updated: Aug 10, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST
R D MacArthur1, L Chen, D L Mayers
1University Health Center, Wayne State University, 4201 St. Antoine, UHC 7-D, Detroit, MI 48201, USA. rmacarthur@intmed.wayne.edu
Abstract:
The CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial is a large, long-term, randomized, prospective comparison of three different antiretroviral strategies in highly active antiretroviral therapy-naïve, HIV-1-infected persons. The trial was designed as a flexible framework upon which other studies could be added to answer more limited, but still important, questions. This article presents the study design, discusses the challenges we have faced in implementing the trial, and describes our preliminary experiences. Control Clin Trials 2001;22:176-190
Related Concept Videos
Retrovirus Life Cycles
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview

